| Name | Title | Contact Details |
|---|
North Canton Medical Foundation was founded in 1972 by a group of physicians who envisioned a non-profit physician group practice as a unique mechanism to bring high quality medical care to the community. Since 1972, North Canton Medical Foundation has
Cayce's Pharmacy is a Hopkinsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The Company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1200 people worldwide, IBA has installed systems across the world, from Europe and the US and to the emerging markets.
Orgain, Inc. was founded by Andrew Abraham M.D. in 2008 . Orgain is the world's first organic drinkable meal on-the-go and is used by physicians, top nutritionists, professional athletes, and health conscious consumers across the nation. Orgain is nationally distributed at Whole Foods, Wegman's, Walgreens, CVS, Rite-Aid, Sprouts, Vitamin Shoppe, Mother's Market, Fairway Markets and many more -- over 15,000 retailers!
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.